The effectiveness of intervention based on family psycho-education in reducing positive and negative symptoms of patients with schizophrenia

The effectiveness of intervention based on family psycho-education in reducing expressed emotion, quality of life, mental health, Knowledge of disease on families of patients with schizophrenia and its impact on reducing positive and negative symptoms of the disease, Adherence to Drug Therapy and Insight

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016081729402N1

Enrollment

Registered

2017-01-08

Start date

2016-10-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia

Interventions

Intervention 1: In Group psychoeducation training, program by the researcher, in 6 sessions (twice a week) based on the third edition of the implementation of psycho-educational sessions (Mottqy Pur,

Treatment - Other

In Group psychoeducation training, program by the researcher, in 6 sessions (twice a week) based on the third edition of the implementation of psycho-educational sessions (Mottqy Pur, 1387) with her f

Control group will receive thire Usual treatment (meeting with the psychiatrist). In order to observe professional ethics and justice, after the intervention and the implementation of the post-test th

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients in the study entry criteria: Having schizophrenia spectrum disorders diagnostic criteria; Aged 18 to 50 years; Minimum education, Guidance and maximum license; Lack of ECT treatment for at least two months before admission and during hospitalization; At the same time you do not receive psychological therapy or 3 months before entering the study and research both; for the patient and for the family; Patient and family consent to participate in research; Living with a family member for at least three months before admission. Exclusion criteria from the study: Acute phase or active substance abuse? Full criteria of borderline personality disorder ?Having suicidal thoughts? History of severe medical illness? Mental retardation? mental damage? An absence of more than one session? Under the age of 18 years and above 50 years? Comorbidity of substance dependence disorder? The comorbidity of other disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Adherence to Drug Therapy. Timepoint: Before the intervention, after intervention. Method of measurement: Medication Adherence Rating Scale (MARS).;Quality of life. Timepoint: Before the intervention, after the intervention. Method of measurement: World Health Organization Quality of Life Scale-Short Form.;Mental health. Timepoint: Before the intervention, after the intervention. Method of measurement: General Health Questionnaire (GHQ-28).;Expressed emotion. Timepoint: Before the intervention, after the intervention. Method of measurement: Expressed emotion questionnaire (FEQ).;Positive and negative symptoms. Timepoint: Before the intervention, after the intervention. Method of measurement: Positive and Negative Syndrome Scale Kay, Fyzbyn and Appler (1986).;Knowledge of disease. Timepoint: Before the intervention, after the intervention. Method of measurement: Knowledge of Schizophrenia Questionnaire (KASQ).;Insight. Timepoint: Before the intervention, after the intervention. Method of measurement: Insight and Treatment Attitudes questionnaire (ITAQ).	—

Measure

Time frame

Adherence to Drug Therapy. Timepoint: Before the intervention, after intervention. Method of measurement: Medication Adherence Rating Scale (MARS).;Quality of life. Timepoint: Before the intervention, after the intervention. Method of measurement: World Health Organization Quality of Life Scale-Short Form.;Mental health. Timepoint: Before the intervention, after the intervention. Method of measurement: General Health Questionnaire (GHQ-28).;Expressed emotion. Timepoint: Before the intervention, after the intervention. Method of measurement: Expressed emotion questionnaire (FEQ).;Positive and negative symptoms. Timepoint: Before the intervention, after the intervention. Method of measurement: Positive and Negative Syndrome Scale Kay, Fyzbyn and Appler (1986).;Knowledge of disease. Timepoint: Before the intervention, after the intervention. Method of measurement: Knowledge of Schizophrenia Questionnaire (KASQ).;Insight. Timepoint: Before the intervention, after the intervention. Method of measurement: Insight and Treatment Attitudes questionnaire (ITAQ).

—

Secondary

Measure	Time frame
Relapse. Timepoint: 6 months after intervention. Method of measurement: Review patient records and reporting of family.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamad fereidooni

Shiraz University of Medical Sciences

samadpsy@gmail.com+7 136277503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026